Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.84 USD
Change Today -0.03 / -0.17%
Volume 1.8M
BSX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 1:57 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by BOSTON SCIENTIFIC CORP (BSX) in the last 6 months

Announced 04/1/15
75.00M for Xlumena, Inc.
Merger/Acquisition

Boston Scientific Corporation (NYSE:BSX) signed an agreement to acquire Xlumena, Inc. from Ascent Biomedical Ventures, Charter Life Sciences, Western Technology Investment and others for $75 million on April 1, 2015. The agreement comprises of an upfront payment of $62.5 million, an additional payment of $12.5 million upon FDA clearance of the HOT AXIOS product and further sales-based milestones based on sales achieved through 2018. The transaction is expected to close ...
Read More


BSX's price was unchanged after the transaction was announced on 04/1/15.
Investor / Buyer
Boston Scientific Corporation
Creditor / Lender
Ascent Biomedical Ventures
Charter Life Sciences
Prism VentureWorks
Third Point LLC
Western Technology Investment
 
Announced 03/16/15
7.00M for InterVene, Inc.
Private Placement

InterVene, Inc. announced that it will receive $7,215,000 in a round of funding on March 16, 2015. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of March 12, 2015, the company has received $5,923,731 from 52 investors in its first tranche of series A round led by Boston Scientific Corporation. The transaction included participation from members of North Texas Angels Network, ...
Read More


BSX's price was unchanged after the transaction was announced on 03/16/15.
Investor / Buyer
Boston Scientific Corporation
Green Park & Golf Ventures LLC
LaunchCapital LLC
 
Announced 03/2/15
1.65B for American Medical Systems Holdings Inc., Men's Health and Prostate Health Businesses
Merger/Acquisition

Boston Scientific Corporation (NYSE:BSX) agreed to acquire Men’s Health and Prostate Health Businesses from American Medical Systems Holdings Inc. for $1.7 billion on March 2, 2015. The purchase price comprises of $1.6 billion, payable in cash at closing and additional $50 million may be payable in 2017 depending on product revenue milestones of the acquired business during calendar year 2016. Boston Scientific plans to finance the transaction by issuance of $1.6 billion ...
Read More


BSX's price was unchanged after the transaction was announced on 03/2/15.
Investor / Buyer
Boston Scientific Corporation
Creditor / Lender
American Medical Systems Holdings Inc.
 
Announced 11/24/14
Iowa Approach, Inc.
Private Placement

Iowa Approach, Inc. announced that it has received funding from Boston Scientific Corporation on November 24, 2014. The company issued common shares in the transaction.


BSX's price was unchanged after the transaction was announced on 11/24/14.
Investor / Buyer
Boston Scientific Corporation
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BSX:US $17.84 USD -0.03

BSX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $142.31 USD -0.0999
Olympus Corp ¥4,215 JPY -40.00
St Jude Medical Inc $74.36 USD -0.375
Stryker Corp $96.43 USD +0.0319
Zimmer Holdings Inc $113.93 USD -0.53
View Industry Companies
 

Industry Analysis

BSX

Industry Average

Valuation BSX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.3x
Price/Book 3.7x
Price/Cash Flow 127.5x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOSTON SCIENTIFIC CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.